ORIGINAL RESEARCH
Published on 09 Jul 2025
Affibody-based targeting agent 131I-YZHER2: V2 for HER2-positive ovarian cancer xenografts
doi 10.3389/fmed.2025.1507596
- 354 views
1,661
Total downloads
7,234
Total views and downloads
ORIGINAL RESEARCH
Published on 09 Jul 2025
OPINION
Published on 09 Feb 2024
ORIGINAL RESEARCH
Published on 17 Jan 2024
ORIGINAL RESEARCH
Published on 25 Jul 2023